The effect of oral tacrolimus with rectal indomethacin to reduce pancreatitis
- Conditions
 - Pancreatitis after ERCP.Other acute pancreatitisK85.8
 
- Registration Number
 - IRCT20240327061376N1
 
- Lead Sponsor
 - Mashhad University of Medical Sciences
 
- Brief Summary
 Not available
- Detailed Description
 Not available
Recruitment & Eligibility
- Status
 - Complete
 
- Sex
 - All
 
- Target Recruitment
 - 78
 
Normal amylase and lipase levels before ARCP
All patients who meet the criteria for performing RCPI
Having informed consent
Full consciousness
• No contraindications for tacrolimus
Pregnancy or breastfeeding
History of previous angina, myocardial infarction, cerebral ischemia during the previous three months
• Chronic heart, liver and kidney failure
Referral with manifestations of acute pancreatitis or chronic pancreatitis
• Tacrolimus contraindications include: uncontrolled blood pressure, uncontrolled infections, hypomagnesemia, hypocalcemia, hyperkalemia, and any type of malignancy.
• Heart rhythm disorders
• Thrombosis and DVT
Study & Design
- Study Type
 - interventional
 
- Study Design
 - Not specified
 
- Primary Outcome Measures
 Name Time Method 
- Secondary Outcome Measures
 Name Time Method 
